Studies have found that the solute carrier family 7 member 11 (SLC7A11) gene is overexpressed in pancreatic cancer cells, and the survival time of mice with SLC7A11 gene deletion induced by CRISPR-Cas9 is doubled compared with that of normal mice [63]. The gene discussed is SLC7A11; the disease is familial pancreatic carcinoma.